查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1982774

全球布氏桿菌症疫苗市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Brucellosis Vaccines Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 162 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

布氏桿菌症疫苗市场预计将从 2025 年的 8.6 亿美元成长到 2034 年的 15.6 亿美元，2026 年至 2034 年的复合年增长率为 6.79%。

随着全球布氏桿菌症疫苗市场日益受到关注，因为控制这种影响牲畜并可感染人类的感染疾病的努力正在不断加强。布氏桿菌症会导致动物繁殖障碍，并造成农业部门经济损失。接种疫苗在预防疾病传播和保护牲畜种群方面发挥着至关重要的作用。

布氏桿菌症疫苗市场成长受多种因素推动。对提高牲畜健康和生产力的需求不断增长，促使农民和政府实施疫苗接种计划。此外，人们对通用感染疾病及其对公共卫生影响的认识不断提高，凸显了有效疾病预防策略的重要性。

随着世界各国政府加强动物疫病防治，布氏桿菌症疫苗市场预计将会成长。兽用疫苗研发的进步可望提高疫苗的有效性和安全性。此外，加大对动物健康研发和农业生产力的投资，也可能推动市场长期扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球布氏桿菌症疫苗市场：按类型划分

  • 市场分析、洞察与预测
  • RBS1
  • S19
  • B19

第五章 全球布氏桿菌症疫苗市场：依疫苗类型划分

  • 市场分析、洞察与预测
  • DNA疫苗
  • 次单位疫苗
  • 载体疫苗
  • 重组疫苗

第六章：全球布氏桿菌症疫苗市场：以动物类型划分

  • 市场分析、洞察与预测
  • 牛
  • 羊
  • 山羊

第七章 全球布氏桿菌症疫苗市场：依最终用户划分

  • 市场分析、洞察与预测
  • 兽医医院和诊所
  • 动物照护中心
  • 其他的

第八章 全球布氏桿菌症疫苗市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第九章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第十章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Creative Biolabs
    • Laboratories Tornel
    • Hester Biosciences Limited
    • Merck & Co. Inc
    • CZ Vaccines
    • Ceva Poultry
    • Fivet Animal Health
    • Colorado Serum Company
    • Indian Immunologicals Ltd
    • Jordan Bio-Industries Center
简介目录
Product Code: VMR11212417

The Brucellosis Vaccines Market size is expected to reach USD 1.56 Billion in 2034 from USD 0.86 Billion (2025) growing at a CAGR of 6.79% during 2026-2034.

The global brucellosis vaccines market has gained attention due to increasing efforts to control this infectious disease that affects livestock and can also infect humans. Brucellosis causes reproductive problems in animals and economic losses in the agricultural sector. Vaccination plays a critical role in preventing disease spread and protecting livestock populations.

Several factors are driving the growth of the brucellosis vaccines market. Rising demand for livestock health management and improved animal productivity has encouraged farmers and governments to adopt vaccination programs. Additionally, growing awareness about zoonotic diseases and their impact on public health has increased the importance of effective disease prevention strategies.

In the future, the brucellosis vaccines market is expected to grow as governments strengthen animal disease control programs. Advances in veterinary vaccine development may improve vaccine effectiveness and safety. Furthermore, increasing investments in animal health research and agricultural productivity will likely support long-term market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • RBS1
  • S19
  • B19

By Vaccine

  • DNA Vaccine
  • Subunit Vaccine
  • Vector Vaccine
  • Recombinant Vaccine

By Animal Type

  • Cattle
  • Sheep
  • Goat

By End User

  • Veterinary Hospitals and Clinics
  • Animal Care Centers
  • Other

COMPANIES PROFILED

  • Creative Biolabs, Laboratories Tornel, Hester Biosciences Limited, Merck Co Inc, CZ Vaccines, Ceva Poultry, Fivet Animal Health, Colorado Serum Company, Indian Immunologicals Ltd, Jordan Bioindustries Center
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BRUCELLOSIS VACCINES MARKET: BY TYPE 2022-2034 (USD MN and Million Doses)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. RBS1 Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.3. S19 Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.4. B19 Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL BRUCELLOSIS VACCINES MARKET: BY VACCINE 2022-2034 (USD MN and Million Doses)

  • 5.1. Market Analysis, Insights and Forecast Vaccine
  • 5.2. DNA Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.3. Subunit Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.4. Vector Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.5. Recombinant Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL BRUCELLOSIS VACCINES MARKET: BY ANIMAL TYPE 2022-2034 (USD MN and Million Doses)

  • 6.1. Market Analysis, Insights and Forecast Animal Type
  • 6.2. Cattle Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.3. Sheep Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.4. Goat Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL BRUCELLOSIS VACCINES MARKET: BY END USER 2022-2034 (USD MN and Million Doses)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Veterinary Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.3. Animal Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 8. GLOBAL BRUCELLOSIS VACCINES MARKET: BY REGION 2022-2034(USD MN and Million Doses)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.2.1 By Type
    • 8.2.2 By Vaccine
    • 8.2.3 By Animal Type
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.3.1 By Type
    • 8.3.2 By Vaccine
    • 8.3.3 By Animal Type
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.4.1 By Type
    • 8.4.2 By Vaccine
    • 8.4.3 By Animal Type
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.5.1 By Type
    • 8.5.2 By Vaccine
    • 8.5.3 By Animal Type
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.6.1 By Type
    • 8.6.2 By Vaccine
    • 8.6.3 By Animal Type
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BRUCELLOSIS VACCINES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Creative Biolabs
    • 10.2.2 Laboratories Tornel
    • 10.2.3 Hester Biosciences Limited
    • 10.2.4 Merck & Co. Inc
    • 10.2.5 CZ Vaccines
    • 10.2.6 Ceva Poultry
    • 10.2.7 Fivet Animal Health
    • 10.2.8 Colorado Serum Company
    • 10.2.9 Indian Immunologicals Ltd
    • 10.2.10 Jordan Bio-Industries Center